China is putting more foreign drug firms under scrutiny, state media said yesterday, days after the conclusion of a police probe into alleged bribery by employees of Britain’s GlaxoSmithKline (GSK).
Earlier this month, Chinese authorities ended a nearly one-year probe into GSK, accusing a top British executive of ordering employees to commit bribery and handing the case over to prosecutors.
Health authorities in the eastern city of Hangzhou were looking into the business practices of further drug companies, including US-based Eli Lilly, Britain’s AstraZeneca and Novo Nordisk of Denmark, the 21st Century Business Herald newspaper reported, citing an internal document.
Another company, Swiss pharmaceuticals giant Roche, said last week that Chinese officials had paid a visit to its offices in Hangzhou.
The GSK case came to light in June last year through a local investigation, after police in the central Chinese city of Changsha announced they were examining the company’s employees for “economic crimes.”
The 21st Century Business Herald said Eli Lilly, AstraZeneca and Novo Nordisk were required to conduct self-inspections for kickbacks and report to local authorities.
However, Eli Lilly yesterday denied it had been approached by Hangzhou authorities.
“Lilly has not been contacted by [the] Hangzhou Health Bureau,” the company said in a statement provided to Agence France-Presse.
“We fully cooperate with any inquiries we receive from [the] government and its agencies in China,” it added.
AstraZeneca and Novo Nordisk did not immediately respond to request for comment.
China’s healthcare sector is widely considered to be riddled with graft, given the opaque tendering system for drugs and doctors’ low salaries.
The government last year launched sweeping probes into alleged malpractice by foreign companies in several sectors and against the backdrop of an anti-graft campaign backed by Chinese President Xi Jinping (習近平) to root out official corruption.
Stephen Garrett, a 27-year-old graduate student, always thought he would study in China, but first the country’s restrictive COVID-19 policies made it nearly impossible and now he has other concerns. The cost is one deterrent, but Garrett is more worried about restrictions on academic freedom and the personal risk of being stranded in China. He is not alone. Only about 700 American students are studying at Chinese universities, down from a peak of nearly 25,000 a decade ago, while there are nearly 300,000 Chinese students at US schools. Some young Americans are discouraged from investing their time in China by what they see
MAJOR DROP: CEO Tim Cook, who is visiting Hanoi, pledged the firm was committed to Vietnam after its smartphone shipments declined 9.6% annually in the first quarter Apple Inc yesterday said it would increase spending on suppliers in Vietnam, a key production hub, as CEO Tim Cook arrived in the country for a two-day visit. The iPhone maker announced the news in a statement on its Web site, but gave no details of how much it would spend or where the money would go. Cook is expected to meet programmers, content creators and students during his visit, online newspaper VnExpress reported. The visit comes as US President Joe Biden’s administration seeks to ramp up Vietnam’s role in the global tech supply chain to reduce the US’ dependence on China. Images on
New apartments in Taiwan’s major cities are getting smaller, while old apartments are increasingly occupied by older people, many of whom live alone, government data showed. The phenomenon has to do with sharpening unaffordable property prices and an aging population, property brokers said. Apartments with one bedroom that are two years old or older have gained a noticeable presence in the nation’s six special municipalities as well as Hsinchu county and city in the past five years, Evertrust Rehouse Co (永慶房產集團) found, citing data from the government’s real-price transaction platform. In Taipei, apartments with one bedroom accounted for 19 percent of deals last
US CONSCULTANT: The US Department of Commerce’s Ursula Burns is a rarely seen US government consultant to be put forward to sit on the board, nominated as an independent director Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, yesterday nominated 10 candidates for its new board of directors, including Ursula Burns from the US Department of Commerce. It is rare that TSMC has nominated a US government consultant to sit on its board. Burns was nominated as one of seven independent directors. She is vice chair of the department’s Advisory Council on Supply Chain Competitiveness. Burns is to stand for election at TSMC’s annual shareholders’ meeting on June 4 along with the rest of the candidates. TSMC chairman Mark Liu (劉德音) was not on the list after in December last